Read more

October 18, 2019
2 min watch
Save

VIDEO: Bimatoprost SR shows continued IOP lowering at 1 year

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN FRANCISCO — At the American Academy of Ophthalmology annual meeting, E. Randy Craven, MD, discusses a study showing the long-term IOP-lowering effect of the Bimatoprost SR implant from Allergan.